U.S. Food and Drug Administration Sr Financial Analyst Salaries in Baltimore, MD
The average U.S. Food and Drug Administration Sr Financial Analyst in Baltimore, MD earns an estimated $88,685 annually, which includes an estimated base salary of $82,441 with a $6,244 bonus. U.S. Food and Drug Administration's Sr Financial Analyst compensation is $1,275 more than the US average for a Sr Financial Analyst. Sr Financial Analyst salaries at U.S. Food and Drug Administration in Baltimore, MD can range from $55,000 - $123,500.
In Baltimore, MD, The Finance Department at U.S. Food and Drug Administration earns $5,183 more on average than the Operations Department.
Last updated 3 years ago.
- $82,441
- avg. base
- $6,244
- avg. bonus
Sr Financial Analyst Salaries at U.S. Food and Drug Administration
In Baltimore, MD, Sr Financial Analysts earn $2,178 more than Financial Analysts, and $2,763 less than Business Analysts.
Compensation at U.S. Food and Drug Administration by Department
In Baltimore, MD, The Finance Department averages $5,183 more than the Operations Department, and $10,226 less than the Business Development Department
Sr Financial Analyst Compensation by Gender (All Companies)
The average female Sr Financial Analyst at companies similar size to U.S. Food and Drug Administration reported making $93,556, while the average male Sr Financial Analyst at similar sized companies reported making $91,853.
Sr Financial Analyst Compensation by Ethnicity (All Companies)
The average Asian or Pacific Islander Sr Financial Analyst at companies similar size to U.S. Food and Drug Administration reported making $98,729, while the average Native American Sr Financial Analyst at similar sized companies reported making $60,000.
How Sr Financial Analysts at U.S. Food and Drug Administration Rate Their Compensation
The majority of Sr Financial Analysts at U.S. Food and Drug Administration believe they're compensated fairly. 100% of Sr Financial Analysts at U.S. Food and Drug Administration say they receive annual bonuses, and the vast majority (71%) are satisfied with their benefits. See more compensation ratings at U.S. Food and Drug Administration
